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Abstract: Sialic acid (Sia) is considered as one of the most important biomolecules of life since its 
derivatives and terminal orientations on cell membranes and macromolecules play a major role in 
many biological and pathological processes. To date, there is only a limited number of active mole-
cules that can selectively bind to Sia and this limitation has made the study of this glycan challeng-
ing. The lectin superfamily is a well-known family of glycan binding proteins, which encompasses 
many strong glycan binding peptides with diverse glycan affinities. Mistletoe lectin (ML) is consid-
ered one of the most active members of lectin family which was initially classified in early studies 
as a galactose binding lectin; more recent studies have suggested that the peptide can also actively 
bind to Sia. However, the details with respect to Sia binding of ML and the domain responsible for 
this binding are left unanswered because no comprehensive studies have been instigated. In this 
study, we sought to identify the binding domain responsible for the sialic acid affinity of mistletoe 
lectin isoform I (MLI) in comparison to the binding activity of elderberry lectin isoform I (SNA), 
which has long been identified as a potent Sia binding lectin. In order to execute this, we performed 
computational carbohydrate-protein docking for MLB and SNA with Neu5Ac and β-Galactose. We 
further analyzed the coding sequence of both lectins and identified their glycan binding domains, 
which were later cloned upstream and downstream to green fluorescent protein (GFP) and ex-
pressed in Escherichia coli (E. coli). Finally, the glycan affinity of the expressed fusion proteins was 
assessed by using different biochemical and cell-based assays and the Sia binding domains were 
identified. 
Keywords: lectin; sialic acid; glycan binding protein 
 
1. Introduction 
The plant kingdom is a rich of source of glycan binding peptides with vast diversity 
spread throughout the kingdom and the occurrence of a specific peptide is not often re-
stricted to a specific plant family. Lectins are one of the most abundant family of glycan 
binding peptides observed in almost all plant families which can actively bind to carbo-
hydrates through different types of non-covalent interactions, such as hydrophobic inter-
actions, hydrogen bonds and metal coordination. Furthermore, the existence of a large 
number of hydroxyl groups on the surface of glycans makes them an appropriate binding 
partner for lectins, especially in the complex networks of hydrogen bonds where the hy-
droxyl groups function as both donor and acceptor [1,2]. 
Whilst the multivalent nature of lectins probably provides them with ultimate selec-
tivity, their specificity to a primary monosaccharide is a major factor in their carbohydrate 
recognition and it is usually an indicator for a particular branched carbohydrate to be 
recognized by a specific lectin. Thus, complex carbohydrates bearing glucose (Glc) or 
mannose (Man) are bound by the Glc/Man-specific lectins (e.g., Lathyrus ockrus and Con 
A) but galactose (Gal)-specific lectins (e.g., Erythrina corallodendron, EcorL) require the 
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presence of Gal to perform this binding [3,4]. Lectins can also agglutinate cells because of 
their divalent or oligovalent structures, which provides each lectin molecule at least two 
glycan binding sites. This provides the lectin molecules with an ability to bind to mem-
brane polysaccharides and glycoproteins and helps cross-linking between cells via their 
cell surface carbohydrates or between other molecules bearing carbohydrates [5]. 
Mistletoe lectin (ML) from (Viscum album L.) is a non-leguminous lectin composed of 
three different isoforms: MLI (viscumin), MLII and MLIII. Each isoform is composed of a 
toxic chain and a glycan binding chain [6]. Despite the fact that these three isoforms have 
very similar primary coding sequences, they possess different carbohydrate binding af-
finities. Isoform one (MLI) is known to possess affinity toward D-galactose, which is 120-
fold stronger than its affinity to N-acetylgalactosamine (GalNAc) [7]. The second isoform 
(MLII) has equivalent affinity to both D-galactose and GalNAc, whereas the third (MLIII) 
isoform has affinity only to GalNAc. These three isoforms are also different in terms of-
molecular weight as both the toxic chain (A) and the binding chain (B) of MLI (A: 29 kDA, 
B: 34 kDA) are larger than the chains of MLII and MLIII (A: 27 kDA, B: 32 kDA) (A: 25 
kDA, B: 30 kDA), respectively [7–9]. 
The main and major isoform of mistletoe lectin is isoform one (MLI), which provides 
immunomodulatory potency to the lectin and it is a type II ribosome-inactivating protein 
(RIPII). The A-subunit of MLI is a toxic protein domain and contains a highly specific N-
glycosidase which can effectively halt cellular protein synthesis via modifying the 28S 
rRNA of the eukaryotic ribosome 60S subunit. The B-subunit of MLI is a glycan binding 
domain that also increases the cytotoxicity of the toxic subunit by causing cell agglutina-
tion and facilitation of cell internalization [9,10]. 
Sialic acid is the most common type of terminal groups of vertebrate carbohydrates 
with a surprising taxonomic distribution found in both the deuterostome lineage animals 
and some of their pathogens [11,12]. The two main types of sialic acid are N-glycolylneu-
raminic acid (Nau5Gc) and N-acetylneuraminic acid (Nau5Ac), as the former (Nau5Gc) 
comes from the latter (Nau5Ac) after hydroxylation of its acetyl group by CAMP-Nau5Ac 
hydroxylase (CMAH). Mammalian cells possess excessive amounts of sialic acid on their 
membrane pericellular matrix (glycocalyx) and this sialylation pattern on cell membranes 
changes in diseased cells, for example, the N-glycans of the oligosaccharides on the mem-
brane of melanoma cancer cells were analyzed by Hoja-Łukowicz and colleagues at dif-
ferent progression stages (primary and metastasis). The cells were found highly and ab-
normally sialilated with an abundant amount of α2-6-linked sialic acids, especially on the 
L1CAM oligosaccharides on the outer membrane of metastatic melanoma cells [13,14]. 
The experimental identification of the structural binding sites between glycan bind-
ing proteins (GBP) and glycans requires three-dimensional structures (3D) of both parts, 
which is not easy to accomplish with crystallography due to various issues such as glycans 
intrinsic resistance to crystallization. The development of advanced tools to theoretically 
predict the structure of glycans has facilitated the augmentation of experimental data and 
conquered some of these limitations [15]. The study of receptor recognition by GBPs has 
also widely expanded and extended into various fields ranging from biology [16] to med-
icine [17,18] and biomass polysaccharide recognition [19]. The biggest step forward in de-
termining GBP specificity was the introduction of glycan array screening, which allowed 
researchers to determine various glycans that can be recognized by a particular GBP [20]. 
However, despite providing a significant dataset screening such as this, there are still lim-
itations, particularly, in terms of presentation of the ligand on the array [21]. Thus, the 
combination of both computational and laboratory experimental screening as presented 
here could be an ideal option to further explore the glycan affinity of different GBPs. 
  




2.1. Protein Sequence Analysis 
The alignment of full sequences of MLI and SNA against the sequences of previously 
known glycan binding lectins helped to identify the exact position of the main toxic A and 
glycan binding B domains of MLI and SNA. Numbers of glycan binding subdomains were 
also identified among the main glycan binding domains as shown in Figure 1. 
 
Figure 1. Analysis map of MLI and SNA coding sequences. 
2.2. Virtual Identification of the Glycan Binding Pockets 
The virtual Glycan-GBP docking was used as a first step to identify the potential 
Neu5Ac binding pocket on MLB. In order to conduct this, the structure of both Neu5Ac 
and β-Galactose (Gal) was docked against the binding domain of both MLI (MLB) and 
SNA (SNA-B). The detected binding poses with the highest affinity of 5.0 and 5.4 kcal/mol 
in the docking of MLB with Neu5Ac and Gal, respectively, showed that both glycans bind 
to the same pocket on MLB but with a short distance between their binding sites (Figure 
2a). Several binding interactions were detected between MLB and Neu5Ac as follows: the 
oxygen atoms on the carboxyl group of Neu5AC were observed to interact with the back-
bone NH of Ile 93 and side chain indole NH of Trp 94 through an ionic bond; on the other 
side of the glycan, the O7 and O8 atoms H-bonded to the side chain COO of Asp 2 and 
Asp 211, respectively; the O9 atoms H-bonded to the side chain carbonyl of Asn 35. How-
ever, the binding of Gal to MLB appeared only through H-bonding of O3 and O6 atoms 
to the side chain carbonyl of Asn 36. 
The binding of SNA to Neu5Ac and β-Galactose was observed to be different than 
the binding of MLB as both glycans attached to the exact site on the exact pocket of SNA 
with the affinity of 6.2 and 5.8 kcal/mol for SNA + Neu5Ac and SNA + Gal, respectively 
(Figure 2b). The binding of both glycans was found to be solely though H-bonding to Asp 
44, Ser 45 and Asp 47. The carboxylic group of Asp 44 was found H-bonded to O5 and O9 
atoms of Neu5Ac and O3 and O4 atoms of Gal. The side chain OH of Ser 45 was found H-
bonded to O4 and O3 atoms of Neu5Ac and Gal, respectively, but its backbone CO was 
found H-bonded to O2 and O4 atoms of Neu5Ac and Gal, respectively. Finally, the back-
bone NH of Asp 47 was found H-bonded to O9 atom of Neu5Ac but its backbone CO was 
found H-bonded to O6 atom of Gal. 
These results suggest that the sialic acid and galactose binding sites on MLB are lo-
cated on two different areas of the same pocket, which allows the protein to bind to both 
glycans simultaneously. However, the binding of both glycans to the same site of the same 
pocket on SNA-B suggests that the protein has ability to bind to both glycans but the 
higher affinity of SNA toward Neu5Ac may increase the chance of binding with Nue5Ac 
more than galactose. 




Figure 2. Binding poses of virtual docking. (a) MLB + Neu5Ac and β-Galactose; (b)SNA-B + Neu5Ac 
and β-Galactose. 
2.3. PCR Amplification of MLA and MLB 
The sequences of the toxic chain (MLA) and the binding chain (MLB) of mistletoe 
lectin, 762 bp and 789 bp, respectively, were successfully amplified using cDNA templates 
reverse transcribed from the total RNA of European mistletoe. The extracted RNA was 
visualized on a formaldehyde electrophoreses gel, as shown in Figure 3A, and the size of 
the amplified chains is confirmed by electrophoresis agarose gel as shown in Figure 3B. 
 
Figure 3. (A) Formaldehyde electrophoreses gel (1%). Lane 1: RNA size marker; Lane 2 and 3: two 
different total RNA samples from mistletoe leaves. (B) Agarose gel (1%) showing amplified chain A 
and chain B of mistletoe lectin. Lane 1: HyperLadder I; Lane 2: amplified chain A (MLA); Lane 3: 
amplified chain B (MLB). 
Several sequencing reactions were also performed on three biological replicates of 
the amplified products to eliminate the possible experimental false mismatch. We found 
that the coding sequences of both chains were slightly different than compared to the 
query sequence on NCBI GeneBank (AY377890.1) and some base mismatches were de-
tected in both MLA and MLB chains. The result of the alignment of amplified MLA and 
MLB sequences with the query sequences showed that MLA had seven amino acids mu-
tated as follows: ATA (Isoleucine), GTT (Valine), ATG (Methionine) and CAG (Gluta-
mine) were replaced with TTA (Leucine), ATT (Isoleucine), GTG (Valine) and CAT (His-
tidine), respectively (Figure S1 in Supplementary Data). Moreover, MLB had three amino 
acids mutated as follow: GAA (Glutamine acid), ATC (Isoleucine) and GTG (Valine) were 
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replaced with GGA (Glycine), GTC (Valine) and GCG (Alanine), respectively (Figure S2 
in Supplementary Data). 
We believe that the main reason behind those mutations was the origin of the mistle-
toe plants, which were from the United Kingdom and Ukraine for our sequence and the 
query sequence, respectively. 
2.4. Lectin-GFP Fusion Proteins 
Since the sialic acid binding activity of the binding domain of mistletoe lectin isoform 
I (MLB) alone and without the toxic domain (MLA) had never been examined separately, 
we N/C-terminally fused the MLB sequence to green florescent protein (GFP) in order to 
generate two recombinant fusion proteins for subsequent sialic acid binding characteriza-
tion. The same fusion proteins were also generated for the binding domain (SNA-B) of 
elderberry lectin (Sambucus nigra), which is a well-known sialic acid binding lectin and 
used as a positive control (Figure 4). All the fusion proteins were successfully expressed 
in E. coli. 
 
Figure 4. Schematic diagram of MLB-GFP and SNA-B-GFP fusion constructs. 
On-plate screening of the fusion proteins was performed to assess the bacterial ex-
pression level of the fusion proteins. The results showed that the fusion proteins made 
from C-terminally fused MLB and SNA-B to GFP were expressed better as they showed 
higher GFP emission than the N-terminally fused MLB and SNA-B to GFP (Figure 5). This 
might be because of the better folding of the proteins or less protein–protein interaction 
between GFP and the lectin domains in the C-terminal cloning orientation. Therefore, the 
C-terminally fused recombinant proteins were selected for the large-scale protein expres-
sion. 
 
Figure 5. On plate protein expresssion screening. Plate (A,B): N-terminally fused MLB and SNA to 
GFP; Plate (C,D): C-terminally fused MLB and SNA to GFP. 
2.5. Affinity Protein Purification 
The purpose of using affinity purification chromatography was to purify the recom-
binant fusion proteins from the total cell lysate as well as the instant assessment of the 
sialic acid binding of the fusion proteins by assessing their binding to the free sialic acid 
residues on the fetuin glycoprotein of the column. The fractions of the purified proteins 
were analyzed with SDS-PAGE and immunoblotting and showed that both N-erminus 
and C-terminus fusion proteins successfully bound to the sialic acid residues. However, a 
higher amount of purified protein was recovered from the elution steps of C-terminally 
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fused recombinant proteins of both MLB and SNA. This indicates that the sialic acid bind-
ing of C-terminally fused proteins was tighter than the N-terminally fused protein as both 
proteins were expressed and purified in identical conditions. This was also compatible 
with our previous finding of the on-plate screening of the fusion proteins (Figure 6). 
 
Figure 6. (a) SDS page of expressed N-terminally and C-terminally fused MLB and SNA-B to GFP. 
Lane 2, 4, 6 and 8 are non-induced protein samples: Lane 3, 5, 7 and 9 are induced protein samples 
from GFP + MLB, MLB + GFP, GFP + SNA and SNA + GFP fusion proteins, respectively. (b,c) SDS 
page of purifird GFP + MLB, MLB + GFP, GFP + SNA and SNA + GFP, respectively. 
2.6. Erythrocytes Hemagglutination by MLB-GFP and SNA-GFP 
The minimum agglutination concentrations (MAC) of MLB-GFP and SNA-GFP fu-
sion proteins to agglutinate erythrocytes were identified by a hemagglutination assay us-
ing 1% sheep erythrocytes. Both fusion proteins agglutinated the erythrocytes at a MAC 
of 0.3 μM and 0.25 μM, respectively. This shows that MLB alone without the toxic domain 
retained the native hemagglutination activity similar to the full-length counterpart lectins. 
Both identified MAC of MLB-GFP and SNA-GFP were then used in the hemaggluti-
nation inhibition assays using a serial dilution of 1% erythrocytes and different hemag-
glutination inhibition agents such as D-Gal, Neu5Ac, D-Glc and sialidase enzyme. The 
fusion proteins were observed to actively agglutinate the erythrocytes when they were 
used alone; however, their hemagglutination activity was partially compromised when 
they were pre-incubated with D-Gal, especially MLB-GFP, which showed slightly less ac-
tivity than SNI-B-GFP (Figure 7). Moreover, both MLB-GFP and SNA-GFP were observed 
to lose their hemagglutination activity when they were pre-incubated with Neu5Ac and 
the main reason could be the pre-occupation of their Sia binding sites by Neu5Ac, which 
prevented them from binding to the terminal Sia on the membrane of erythrocytes and 
subsequently caused reduced agglutination. A similar result was also detected in the case 
of sialidase treated erythrocytes because the cells did not possess terminal Sia on their 
membrane glycoproteins anymore and this stopped them from being bound and agglu-
tinated by MLB-GFP and SNA-GFP. These results suggest that MLB can bind to sialic acid 
similar to SNA. On the other hand, the incubation of both fusion proteins with D-Glc had 
no impact on their agglutination activity; this agrees with the previous findings that both 
fusion proteins have zero affinity for glucose (Figure 7). 




Figure 7. Hemagglutination assay using sheep erythrocytes. First row, untreated erythrocytes; 
Scheme 1. and SNA-B-GFP (2) fusion proteins; third row, erythrocytes dosed with MLB-GFP + Sialic 
acid (1) and SNA-B-GFP + Sialic acid (2); fourth row, erythrocytes dosed with MLB-GFP + Galactose 
(1) and SNA-B-GFP + Galactose (2); fifth row, erythrocytes dosed with MLB-GFP + Glucose (1) and 
SNA-B-GFP + Glucose (2); sixth row, sialidase treated erythrocytes dosed with MLB-GFP (1) and 
SNA-B-GFP (2) fusion proteins. 
2.7. MLB-GFP and SNA-GFP Binding to Mammalian Cells 
The overexpression of α2, 6 sialic acid on the membrane of WM-266-4 metastatic mel-
anoma cells was previously confirmed in a study conducted by Hoja-Łukowicz and Link-
Lenczowsk, 2012. Therefore, we believed that WM-266-4 cell line is a suitable candidate 
for mammalian cell-based activity assessment of the fusion proteins. 
The epifluorescence microscopy screening of WM-266-4 cells treated with MLB-GFP 
and SNA-GFP showed that both fusion proteins successfully attached to the membrane 
of the cells and were successfully internalized across their membranes as the GFP flo-
rescence was detected on the outer surface of the cell membranes as well as inside the cells 
(Figure 8). The cells were also observed to be agglutinated by both fusion proteins, which 
confirms their agglutination activity and this is compatible with the outcome of our he-
magglutination inhibition assay. 
 
Figure 8. Metastatic melanoma cells (WM-266-4) incubated with 0.3 µM of (a) GFP; (b) MLB + GFP 
and (c) SNA + GFP for 24 hours and screened under luminescence imaging microscopy. The RED 
arrows show the attachment of the fusion proteins to the cell membranes and cell agglutination. The 
YELLOW arrows show cell internalization of the fusion proteins. 
3. Discussion 
The vast diversity of sialic acid distribution among different organisms and its crucial 
biological functions render this glycan an important biomolecule to investigate more ex-
tensively, while understanding the biofunctions of this glycan and its derivatives is still 
relatively limited. In order to further study the biological functions of Sia, selective and 
efficient sialic acid binding molecules need to be identified in order to be able to compre-
hensively study the undiscovered functions of the glycan.  
The contradictory outcomes of previous studies regarding the glycan affinity of mis-
tletoe lectin left the affinity of this lectin as an answered question, particularly since older 
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studies classified the lectin as a galactose binding while more recent studies detected sialic 
acid binding activity from an isoform of the lectin. Furthermore, the concept of Sia binding 
of mistletoe lectin remained vague for a long time because only limited experiments were 
conducted and they only focused on sialic acid binding activity of the total MLI isolated 
from extract of mistletoe [22]. Therefore, we used a genetic fusion approach to precisely 
examine the Sia affinity of the binding domain (MLB) of mistletoe lectin isoform I (MLI) 
without the toxic MLA domain in this study. The first binding assay conducted in the 
affinity purification step utilized the terminal sialic acids on the surface of fetuin glyco-
proteins and we discovered that MLB can actively bind to Sia as observed for SNA, which 
is a well-known sialic acid binding lectin. This strongly suggests that the classification of 
mistletoe lectin as a galactose binding lectin was purely due to a lack of experimentation. 
Subsequently, hemagglutination and inhibition assays were necessary for comparing 
the Sia binding of MLB with galactose binding. The slight inhibition of the erythrocyte 
agglutination by galactose treated MLB-GFP confirmed that MLB has the affinity to ga-
lactose as well. This is compatible with the previously reported galactose affinity of mis-
tletoe lectin [23]. However, the agglutination inhibition caused by galactose was not as 
strong as the inhibition caused by the Sia treated MLB-GFP and this provides a clear indi-
cation that MLB binds to the terminal Sia on erythrocytes stronger than binding to galac-
tose. Moreover, the binding of both MLB-GFP and SNA-GFP to the terminal Sia on the 
membrane glycoproteins of WM-266-4 human melanoma cells confirmed the fact that 
both lectin domains can similarly bind to the Sia rich glycoproteins on the membrane of 
mammalian cells. Furthermore, both binding domains preserved their agglutination ca-
pacity, which is a well-known biological function possessed by their native full-length 
counterpart lectins and a crucial function for facilitating their cell membrane binding and 
cell internalization. The observed activities of mistletoe lectin treatment on human mela-
noma cells are in line with results of a study conducted by Hoja et al. 1995, which investi-
gated the impact of mistletoe lectin treatment on the interleukin-12 (IL-12) secretion in 
human peripheral blood mononuclear cells and the treatment was observed to enhance 
the secretion of an active form of IL-12. 
The results of our computational screening and the assays conducted in this study 
confirm that the binding chain (MLB) of mistletoe lectin isoform I (MLI) can actively bind 
to sialic acid and that the glycan binding activity of both MLB and SNA alone and without 
their toxic domains remains intact. Therefore, both domains could be used as potent bind-
ing agents or monobody to specifically target sialic acid in different biological systems. 
This could eventually permit the use of the domains in biomedical studies as diagnostic 
tools or potentially as therapeutic agents in order to activate certain biological signals via 
binding to sialic acid on specific counter-receptors. 
4. Materials and Methods 
4.1. Chemicals and Reagents 
Pre-activated CNBr Sepharose 4B and HR 16/10 FPLC columns were purchased from 
GE Healthcare. Monoclonal Anti-GFPuv antibody and pGFPuv plasmid were purchased 
from Clontech. Fetuin glycoprotein from fetal bovine serum, β-Galactosidase enzyme, si-
alidase enzyme, goat IgG Anti-Mouse IgG-HRP conjugated secondary antibody, sintered 
glass filter (porosity G3) and all the chemicals (unless it is mentioned) were purchased 
from Sigma-Aldrich (Sigma-Aldrich, UK). 
4.2. Virtual Carbohydrate Docking 
The crystal structures of MLI (2RG9) and SNA (3C9Z) were derived from RCSB Pro-
tein Data Bank as bdp files and they were converted to the final docking structures on 
Glycoprotein Builder tool on the online platform of Glycam project (www.glycam.org Ac-
cessed on 02/03/2021). The structures of Neu5Ac and β-Galactose were drawn on 
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ChemDraw software and converted to 3D structures on Carbohydrate Builder tool on 
Glycam project. The virtual carbohydrate docking was executed by using AutoDock tools. 
4.3. Total RNA Extraction and cDNA Synthesis 
Fresh leaves of European mistletoe plant were ground to a fine powder in liquid ni-
trogen by using mortar and pestle. The RNA extraction was performed by using ISOLATE 
II RNA plant kit (Meridian Bioscience, UK) following the manufacturer’s instructions. The 
quality of the extracted RNA was later assessed on agarose gel electrophoresis containing 
formaldehyde and NanoDrop2000 (Thermo Fisher scientific, USA). The cDNA was re-
verse transcribed using SuperScriptTM-II reverse transcriptase kit (Invitrogen, USA) fol-
lowing the manufacturer’s instructions. 
4.4. Polymerase Chain Reactions (PCR) 
The coding sequences of MLA and MLB chains of MLI were amplified by using re-
verse transcribed cDNA as a DNA template and Q5 High-Fidelity polymerase (NEB) with 
two sets of primer shown in Table 1. 
Table 1. Primers used in polymerase chain reaction, introduced restriction sites and added 
nucleotides shown in red; actual site underscored; main lectin sequence shown in black. 
Primers Sequences TM (°C) 
MLA-fwd AGAGGAAGATGGCCGCTCTC 60 
MLA-rev TACGAGAGGCTAAGACTCAGAG 61 
MLB-fwd GATGATGTTACCTGCAGTGCTTC 60 
MLB-rev TGGCACGGGAAGCCACATTTG 61 
MLB + SacI (fwd) GGA GCT CGC TGC AGC TGC AGA TGA TGT TAC CTG 73 
MLB + EcoRI (rev) CGA ATT CAT TAT GCA GCT GGC ACG GGA AGC CAC 72 
MLB + XbaI (fwd) GCG TCT AGA AAA AGA TGA TGT TAC CTG CAG TGC TTC G 71 
MLB + KpnI (rev) GCA TGA GGT ACC TTT GGC ACG GGA AGC CAC 72 
SNA-B + HindIII (fwd) TGA AAG CTT G GGG GGC GAG TAC GAA AAA 66 
SNA-B + XbaI (rev) TGA TCT AGA GT AGC TGG ATG GGT GGT AGT 66 
4.5. Sequencing Reactions 
The sequencing of the cloned MLA and MLB was carried out using BigDye Termina-
tor cycle sequencing chemistries (Thermo Fisher scientific, USA) and standard forward 
and reverse M13 primers. The Prism 3100 Genetic Analyzer was used to run the capillary 
gels and the analysis of the sequencing data was carried out using SnapGene (SnapGene, 
USA), Chroma Lite and CLC Sequence Viewer (Qiagen, Germany) software. The full-
length sequences of SNA and MLI (MLA and MLB) from the sequencing reactions were 
aligned against the sequences of previously known glycan binding lectins. 
4.6. Lectin-GFP Fusion Proteins 
Fusion proteins were generated from the binding chain (MLB) of both mistletoe lectin 
isoform one (MLI) and elderberry lectin isoform I (SNA-B). A reference gene of SNI-B 
from NCBI (U27122.1) was used as a template sequence for solid synthesis of the gene 
carried out by Eurofins Genomics (Eurofins, Luxembourg). The MLB and SNI-B se-
quences were then cloned in upstream and downstream to the coding sequence of GFP in 
pGFPuv plasmid (Figure 9). 




Figure 9. The cloning map of MLB and SNA-B N/C-terminally fused to green florescent protein 
(GFP) in pGFPuv plasmid. 
4.7. On Plate Induction 
The transformed E. coli cells with the plasmids containing the fusion protein con-
structs were plated on LB-Agar plates, which were surface-covered with 500 uM IPTG. 
The visualization and imaging of the grown colonies were performed under standard UV 
light (360–400 nm). 
4.8. Expression of Recombinant MLB and SNA-B 
The MLB + GFP and SNA-B + GFP fusion constructs were transformed into 
BL21(DE3) strain and plated on antibiotic selection plates (Ampicillin 100 μg/mL). The 
transformed cells were grown overnight in 10 mL of liquid LB with 100 μg/mL ampicillin 
at 37 °C. The overnight culture was added to a litter of fresh LB medium with antibiotic 
and incubated at 30 °C until OD600 0.7 was reached, followed by induction using 500 µM 
IPTG for 18 h. BugBuster protein extraction reagent was used to extract the total soluble 
proteins from the bacterial cells as per manufacture’s instruction. The extracted protein 
was later analyzed by SDS PAGE electrophoresis. 
4.9. Affinity Column Preparation 
Affinity column bed was prepared from the pre-activated CNBr Sepharose 4B which 
is an appropriate medium for immobilization of ligands containing primary amines. The 
medium was coupled with degalactosilated bovine fetuin as a heavily glycosylated pro-
tein containing bi-antennary, tri-antennary and tetra-antennary oligosaccharides with 
variable sialyation. Briefly, the required amount of lyophilized CNBr powder was 
weighed and suspended in 1 mM HCL. The medium swelled immediately and was 
washed on a sintered glass filter (porosity G3) with 1 mM HCl for 15 min. The required 
amount of fetuin (10 mg/mL) was also dissolved in dissolving buffer (0.1 M CH₃COONa, 
pH 8.3; containing 0.5 M NaCl) and incubated at 37 °C overnight with an appropriate 
amount of β-galactosidase to remove the free galactose residues. The fetuin was then ex-
tensively dialyzed against a coupling buffer (0.1 M NaHCO3, pH 8.3; containing 0.5 M 
NaCl) and added to the suspended CNBr medium in a stoppered vessel. The mixture was 
subject to end-overend rotation overnight at 4 °C and washed later with 5 medium (gel) 
volumes of coupling buffer in order to wash away the excess ligands. The mixture was 
incubated in blocking buffer (0.1 M Tris-HCl) pH 8.0 for 2 h to block remaining active 
groups on Sepharose 4B and washed in three cycles of alternating pH with 5 medium 
volumes of 0.1 M acetic acid/sodium acetate, pH 4.0 containing 0.5 M NaCl, and 0.1M Tris-
HCl, pH 8 containing 0.5 M NaCl. Finally, the coupled CNBr-fetuin bead was packed in 
HR 16/10 column. 
4.10. Affinity Purification 
Affinity column chromatography was performed in order to purify the fusion pro-
teins from the total extracted proteins by using the pre-packed CNBr-fetuin column and 
AKTA prime FPLC platform. The column was equilibrated with running buffer (PBS, PH 
6.0) and the effect of PH on the binding of MLB + GFP and SNA + GFP to the column was 
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first analyzed through loading a small scale of MLB, SNA on the column and performing 
elution steps via three different PH (3.0, 6.0 and 9.0) of the elution buffer (PBS alone). The 
UV signal of the eluted fractions was monitored and compared to the elution step of a 
column loaded with only running buffer. At low PH points (3.0 and 6.0), none of the fusion 
proteins were observed to be eluted by the elution buffer and a negligible amount of the 
fusion proteins was eluted at PH 9.0. On the other hand, both fusion proteins were ob-
served to be completely eluted from the column when sialic acid was added to the elution 
buffer at 6.0. Therefore, we decided to use PH 6.0 for the elution buffer, which was PBS 
containing 0.5 M sialic acid. Collected fractions containing the target fusion proteins were 
later analyzed on SDS-PAGE and Western blotting was used with the anti-GFPuv primary 
antibody. 
4.11. Hemagglutination Assay 
Erythrocytes were prepared by washing fresh sheep blood four times with 0.15 M 
NaCl and stored in Alsever’s medium (0.8% sodium citrate, 0.42% sodium chloride, 2.05% 
glucose and 0.055% citric acid) at 4 °C. The blood was centrifuged at 1500g for 5 min to 
precipitate the erythrocytes, which was later washed with PBS four times in the ratio of 
1:5 (v/v). A batch of the washed erythrocytes was treated with 10 unites/mL of sialidase 
enzyme for 2 h at 37 °C in order to remove the free sialic acid residues on their membranes 
and then used in the negative control treatment. Another batch of erythrocytes (4 mL) was 
added to 95 mL of PBS and 0.1% trypsin (w/v) and incubated for 90 min at 37 °C followed 
by four rounds of washing with PBS and diluting it to 1% erythrocytes suspension in PBS. 
Cells were incubated at 4 °C until use. The hemagglutination assay was performed on 96-
well round bottom microtiter plates. In the first step, the minimum agglutination concen-
tration (MAC) of MLB + GFP and SNA-B + GFP fusion proteins was identified by using a 
range of concentrations (0.05–1 µM) of the fusion proteins. For each well containing the 
fusion proteins 50ul of 1% erythrocytes in PBS was added and incubated for two hours at 
room temperature. The agglutination of the erythrocytes was visually assessed. The iden-
tified MAC of both fusions proteins was then used in hemagglutination inhibition assay 
using a serial dilution of 1% erythrocytes. For the control treatments, the fusion proteins 
were pre-incubated with (10 mM) of three hemagglutination inhibitor agents (N-
Acetylneuraminic acid (Neu5Ac), D-galactose (D-Gal) and D-glucose (D-Glc)) for an hour 
at 4 °C. The cells were added last and agglutination was permitted to proceed for 60 min 
at room temperature (22 °C).  
4.12. Mammalian Cell Culture 
Human metastatic melanoma cells (WM-266-4) (ECACC, Salisbury, UK) were cul-
tured in DMEM medium supplemented with 1% (v/v) glutamine and 10% (v/v) fetal bo-
vine serum (FBS) and maintained at 37 °C in a humidified atmosphere containing 5% car-
bon dioxide. 
4.13. Luminescence Imaging Microscop 
Human metastatic melanoma cells (WM 266-4) were plated on a 96-well plate at a 
seeding density of 8000 cells/well (~1.4 × 104 cells/cm2). Following overnight incubation, 
the FBS in the medium was lowered down to 2%. The cells were then treated with 0.3 µM 
of MLB-GFP and SNA-B-GFP fusion proteins and incubated for 18 h. The binding and 
internalization of the fusion proteins into the cells were visualized using luminescence 
imaging microscopy (Nikon, Japan). 
Supplementary Materials: The following are available online at www.mdpi.com/arti-
cle/10.3390/ijms22158284/s1, Figures S1 and S2. Alignment of the sequencing data from three bio-
logical replicates of amplified MLA and MLB sequences respectively aligned with the query se-
quence (NCBI: AY377890.1). Figure S3. The amino acid sequences of Mistletoe lectin-isoform I 
(MLI). MLA sequence is highlighted in green; MLB sequence is highlighted in pink and the linker 
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between MLA and MLB is highlighted in purple. Figures S4 and S5. The full view of computational 
docking of both MLB and SNA with Neu5Ac and β-Galactose respectively. 
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